Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jul;4(2):65-9.

Drug-susceptibility pattern of mycobacterium tuberculosis among pulmonary tuberculosis patients in riyadh, saudi arabia

Affiliations

Drug-susceptibility pattern of mycobacterium tuberculosis among pulmonary tuberculosis patients in riyadh, saudi arabia

S T Al-Awaidy et al. J Family Community Med. 1997 Jul.

Abstract

Objective: To identify the pattern of drug-susceptibility of newly diagnosed pulmonary tuberculosis patients in Riyadh, we conducted a study on all Mycobacterium tuberculosis positive-culture patients admitted to Sahari Chest Hospital from January 1994 to April 1995.

Methods: Demographic data, antituberculous therapy and drug-susceptibility testing results of each patient were reviewed from patients' hospital records. The samples were cultured on Lowenstein-Jensen media and drug susceptibility was tested by Bactec 12B (Middlebrook 7H12) media against selected antituberculous drugs

Results: Drug susceptibility was performed on 362 (91%) of the sputum positive-cultures. The overall initial resistance rate (1 or more drugs) was 12.4%. Initial. resistance was more common with a single drug (9.4%), followed by two drugs (2.3%) and then three drugs (0.3%). Resistance to isoniazid was most common (10.4%), followed by streptomycin (2.7%), rifampicin (1.9%) and ethambutol (0.6%). Single isoniazid resistance was 60%, followed by two drugs: streptomycin and isoniazid (13.3%).

Conclusion and recommendations: Resistance to multiple drugs is not yet a significant problem in Riyadh. A continuous monitoring of drug resistance is important for planning and assessing the national TB control program. Timely and complete reporting is essential to identify the problem as and when it begins.

Keywords: Saudi Arabia; TB; drug susceptibility.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of pulmonary TB cases by age among Saudis and non-Saudis, Sahari Chest Hospital, Riyadh, January 1994 – April 1995

References

    1. Nunn P, Felten M. Surveillance of resistance to antituberculosis drugs in developing countries. Tubercle Lung Dis. 1994;75:163–7. - PubMed
    1. Jarallah JS, Elias AK, Al-Hajjaj MS. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tubercle. 1992;73:113–6. - PubMed
    1. Schiott CR, Engbaek HC, Vergmenn Incidence of drug resistance among isolates of Mycobacterium tuberculosis recovered in the Gizan area, Saudi Arabia. Saudi Med J. 1985;6:375–8.
    1. Zaman R. Tuberculosis in Saudi Arabia: initial and secondary drug resistance among endogenous and non-endogenous population. Tubercle. 1991;72:51–5. - PubMed
    1. Zaman R. Mycobacterium infections in Jeddah: a retrospective study. Med Sci Res. 1988;16:117–18.